Skip to main content
SpringerLink
Log in

Neuropathological endpoints in experimental stroke pharmacotherapy: The importance of both early and late evaluation

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

This study adresses the issue of endpoint selection in the evaluation of neuroprotective drugs in experimental focal ischaemia. Previous work with the permanent middle cerebral artery (MCA) occlusion model in the rat has demonstrated that the ischaemic lesion does not acquire its final appearance until at least 28 days after the ictus. Therefore, the effect of the NMDA receptor blocker MK-801 (dizocilpine maleate) was evaluated both early (3 days) and late (28 days) after MCA occlusion to determine if the previously reported protective effect of a single post-ischaemic dose of MK801 found in acute experiments remained after 28 days.

Mk-801 (0.5mg/kg, i.v.) or isotonic saline was randomly given to rats 30 min after MCA occlusion. Infarct volume and volume of ipsilateral and contralateral hemispheres were estimated from camera lucida drawings of 8 defined coronal histological sections of the brain. As expected, a 40% (p<0.05) reduction of infarct size was found in MK-801 treated rats after 3 days. In animals evaluated 28 days after MCA occlusion, no significant difference in infarct size, total tissue loss (infarct volume + ipsilateral hemisphere atrophy) or remaining non-infarcted tissue (contralateral hemisphere — total tissue loss) was seen between the MK-801 and placebo treated rats.

The results suggest that the single dose treatment with MK-801 postponed the evolution of the infarct, which at 3 days after MCA occlusion is still in progress, possibly by ameliorating oedema formation. It remains to be shown if a multiple dose treatment with NMDA receptor antagonists improves the final neuropathological outcome after experimental stroke. The study illustrates the importance of including a late endpoint when evaluating the efficacy of neuroprotective stroke therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tamura A, Graham DI, McCulloch J, Teasdale TM (1981) Focal cerebral ischemia in the rat. 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1: 53–60

    PubMed  Google Scholar 

  2. Persson L, Hårdemark H-G, Bolander H, Hillered L, Olsson Y (1989) Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke 20: 641–645

    PubMed  Google Scholar 

  3. Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM, Graham DI (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurosurg Psychiatry 50: 402–410

    Google Scholar 

  4. Kirino T, Tamura A, Sano K (1984) Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol (Berl) 64: 139–147

    Google Scholar 

  5. Ginsberg MD, Busto R (1989) Rodent models of cerebral ischemia. Stroke 20: 1627–1642

    PubMed  Google Scholar 

  6. Albers GW, Goldberg MP, Choi DW (1989) N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 25: 398–403

    PubMed  Google Scholar 

  7. Scatton B, Carter C, Benavidès J, Giroux C (1991) N-methyl-D-aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischemic brain injury. Cerebrovasc Dis 1: 21–135

    Google Scholar 

  8. Bolander HG, Persson L, Hillered L, d'Argy R, Pontén U, Olsson Y (1989) Regional cerebral blood flow changes after middle cerebral artery occlusion in rats. Stroke 20: 930–937

    PubMed  Google Scholar 

  9. Ozyurt E, Graham DI, Woodruff GN, McCulloch J (1988) Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 8: 138–143

    PubMed  Google Scholar 

  10. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J (1988a) The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 24: 543–551

    PubMed  Google Scholar 

  11. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J (1988b) Focal cerebral ischemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischemia. J Cereb Blood Flow Metab 8: 757–762

    PubMed  Google Scholar 

  12. Gotti B, Benavidès J, MacKenzie ET, Scatton B (1990) The pharmacotherapy of focal cortical ischemia in the mouse. Brain Res 522: 290–307

    PubMed  Google Scholar 

  13. Bielenberg GW, Beck T (1991) The effects of dizocilpine (MK-801), phencyclidine and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat. Brain Res 552: 338–342

    PubMed  Google Scholar 

  14. Gill R, Andiné P, Hillered L, Persson L, Hagberg H (1992) The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischemia in the rat. J Cereb Blood Flow Metab 12: 371–379

    PubMed  Google Scholar 

  15. Valtysson J, Hillered L, Andiné P, Hagberg H, Persson L (1991) Long-term effects of MK-801 on the size of the ischemic lesion in MCA occluded rats. J Cereb Blood Flow Metab 11 [Suppl 2]: 284

    Google Scholar 

  16. Persson L, Valtysson J, Andiné P, Hagberg H, Hillered L (1992) Neuropathologic end points in experimental stroke therapy (MK-801): the importance of both early and late evaluation. Soc Neurosci Abstr 18: 1452

    Google Scholar 

  17. Hillered L, Kotwica Z, Ungerstedt U (1991) Interstitial and cerebrospinal fluid levels of energy-related metabolites after middle cerebral artery occlusion in rats. Res Exp Med 191: 219–225

    Google Scholar 

  18. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis, Barktowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke 17: 472–476

    PubMed  Google Scholar 

  19. Hårdemark H-G, Persson L, Bolander H, Hillered L, Olsson Y, Påhlman S (1988) Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid. Stroke 19: 1140–1144

    PubMed  Google Scholar 

  20. Blackwood W (1969) Vascular disease of the central nervous system. In: Blackwood W, McMenemey HW, Meyer A, Norman RM, Russel DS (eds) Greenfield's neuropathology. Edward Arnold, London, pp 71–137

    Google Scholar 

  21. Graham DI (1985) The pathology of brain ischemia and possibilities for therapeutic intervention. Br J Anaesth 57: 3–17

    PubMed  Google Scholar 

  22. Katzman R, Clasen R, Klatzo I, Stirling Meyer J, Pappius HM, Waltz AG (1977) Brain edema in stroke. Stroke 8: 510–540

    Google Scholar 

  23. Thoumas K-å, Kotwica Z, Bergström K, Bolander HG, Hillered L, Olsson Y, Pontén U, Persson L (1991) MRI of cerebral ischaemia in rats with occlusion of the middle cerebral artery. Eur Radiol 1: 118–123

    Google Scholar 

  24. Nedergaard M, Astrup J (1986) Infarct rim: effect of hyperglycemia on direct current potential and [14C]2-deoxyglucose phosphorylation. J Cereb Blood Flow Metab 6: 607–615

    PubMed  Google Scholar 

  25. Hillered L, Hallström å, SegersvÄrd S, Persson L, Ungerstedt U (1989) Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J Cereb Blood Flow Metab 9: 607–616

    PubMed  Google Scholar 

  26. Butcher SP, Bullock R, Graham DI, McCulloch J (1990) Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 21: 1727–1733

    PubMed  Google Scholar 

  27. Hansen AJ (1985) Effect of anoxia on ion distribution in the brain. Physiol Rev 65: 101–148

    PubMed  Google Scholar 

  28. Iijima T, Mies G, Hossmann K-A (1992) Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury. J Cereb Blood Flow Metab 12: 727–733

    PubMed  Google Scholar 

  29. Swanson RA, Morton MT, Wu GT, Savalos R, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290–293

    PubMed  Google Scholar 

  30. Lin T-N, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117–121

    PubMed  Google Scholar 

  31. McIntosh TK, Vink R, Soares H, Hayes R, Simon R (1990) Effect of non-competitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J Neurochem 55: 1170–1179

    PubMed  Google Scholar 

  32. Oh SM, Betz AL (1991) Interaction between free radicals and excitatory amino acids in the formation of ischemic brain edema. Stroke 22: 915–921

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Uppsala University Hospital, Sweden

    J. Valtysson, L. Hillered & L. Persson

  2. Department of Clinical Chemistry, Uppsala University Hospital, Sweden

    L. Hillered

  3. Institute of Neurobiology, University of Göteborg, Sweden

    P. Andiné & H. Hagberg

  4. Department of Obstetrics and Gynaecology, University of Göteborg, Sweden

    H. Hagberg

Authors
  1. J. Valtysson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Hillered
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Andiné
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Hagberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Persson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valtysson, J., Hillered, L., Andiné, P. et al. Neuropathological endpoints in experimental stroke pharmacotherapy: The importance of both early and late evaluation. Acta neurochir 129, 58–63 (1994). https://doi.org/10.1007/BF01400874

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01400874

Keywords

Search

Navigation